Total Payments
$237,874
2024 Payments
$777.09
Companies
37
Transactions
309
Medicare Patients
5,107
Medicare Billing
$237,043
Payment Breakdown by Category
Research$229,119 (96.3%)
Food & Beverage$5,369 (2.3%)
Travel$3,366 (1.4%)
Gifts$20.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $229,119 | 9 | 96.3% |
| Food and Beverage | $5,369 | 289 | 2.3% |
| Travel and Lodging | $3,366 | 10 | 1.4% |
| Gift | $20.00 | 1 | 0.0% |
Payments by Type
Research
$229,119
9 transactions
General
$8,755
300 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valneva Austria GmbH | $230,297 | 11 | $0 (2022) |
| Boehringer Ingelheim International GmbH | $1,651 | 11 | $0 (2023) |
| PFIZER INC. | $1,426 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,073 | 12 | $0 (2023) |
| Novo Nordisk Inc | $564.27 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $465.56 | 45 | $0 (2024) |
| ABBVIE INC. | $434.60 | 19 | $0 (2024) |
| Lilly USA, LLC | $351.89 | 23 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $191.17 | 2 | $0 (2022) |
| Amgen Inc. | $185.45 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.09 | 39 | Amgen Inc. ($185.45) |
| 2023 | $3,103 | 67 | Boehringer Ingelheim International GmbH ($1,651) |
| 2022 | $229,657 | 35 | Valneva Austria GmbH ($229,119) |
| 2021 | $224.57 | 12 | AbbVie Inc. ($72.46) |
| 2020 | $549.06 | 18 | Novartis Pharmaceuticals Corporation ($444.54) |
| 2019 | $1,620 | 54 | Valneva Austria GmbH ($1,178) |
| 2018 | $500.30 | 45 | GlaxoSmithKline, LLC. ($158.17) |
| 2017 | $1,442 | 39 | PFIZER INC. ($1,093) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 10/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 10/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $149.04 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.69 | General |
| 07/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: VACCINES | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Inflammation | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED PIVOTAL STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY OF A LIVE-ATTEUATED CHIKUNGUNYA VIRUS VACCINE CANDIDATE (VLA1553) IN ADULTS AGED 18 YEARS AND ABOVE | Valneva Austria GmbH | $200,273 | 7 |
| Alternative schedule study for VLA15, a MULTIVALENT recombinant OspA BASED vaccine CANDIDATE against Lyme borreliosis, IN HEALTHY ADULTS AGED 18 to 65 years - a Randomized, controlled, observer-blind phase 2 study. | Valneva Austria GmbH | $28,846 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 992 | 1,535 | $120,381 | $46,647 |
| 2022 | 23 | 1,392 | 2,234 | $181,923 | $67,981 |
| 2021 | 22 | 1,397 | 2,192 | $177,388 | $67,113 |
| 2020 | 22 | 1,326 | 2,016 | $159,753 | $55,302 |
Total Patients
5,107
Total Services
7,977
Medicare Billing
$237,043
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 289 | $54,910 | $22,563 | 41.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $4,550 | $3,385 | 74.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $3,019 | $2,910 | 96.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 118 | 199 | $13,751 | $2,598 | 18.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 33 | $2,630 | $2,367 | 90.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 121 | 207 | $11,720 | $2,132 | 18.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 122 | 230 | $2,151 | $1,920 | 89.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 13 | $2,925 | $1,913 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 26 | $3,640 | $1,607 | 44.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 112 | $5,888 | $1,066 | 18.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,190 | $1,033 | 86.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 95 | 126 | $4,032 | $951.25 | 23.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 34 | 53 | $3,710 | $872.38 | 23.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 28 | 47 | $3,055 | $415.48 | 13.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 14 | $476.00 | $383.63 | 80.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 32 | 32 | $736.00 | $181.12 | 24.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 32 | 32 | $640.00 | $162.56 | 25.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $803.18 | $105.10 | 13.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 37 | $555.00 | $81.40 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 455 | $86,450 | $36,471 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 73 | $10,220 | $4,049 | 39.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 52 | 52 | $3,900 | $3,496 | 89.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 150 | 263 | $18,173 | $3,450 | 19.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $4,200 | $3,339 | 79.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 19 | $4,240 | $3,070 | 72.4% |
About Dr. Suchet Patel, MD
Dr. Suchet Patel, MD is a Family Medicine healthcare provider based in Endwell, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942229018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suchet Patel, MD has received a total of $237,874 in payments from pharmaceutical and medical device companies, with $777.09 received in 2024. These payments were reported across 309 transactions from 37 companies. The most common payment nature is "" ($229,119).
As a Medicare-enrolled provider, Patel has provided services to 5,107 Medicare beneficiaries, totaling 7,977 services with total Medicare billing of $237,043. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Endwell, NY
- Active Since 07/19/2006
- Last Updated 02/22/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942229018
Products in Payments
- LEQVIO (Drug) $583.68
- VRAYLAR (Drug) $350.52
- JARDIANCE (Drug) $290.70
- Ozempic (Drug) $226.38
- BARD MARQUEE (Device) $191.17
- Repatha (Biological) $149.04
- ANORO (Drug) $134.64
- Saxenda (Drug) $109.43
- CHANTIX (Drug) $101.76
- UBRELVY (Drug) $89.29
- SHINGRIX (Biological) $88.18
- ELIQUIS (Drug) $86.75
- TRULICITY (Drug) $86.67
- TRELEGY ELLIPTA (Drug) $81.88
- Wegovy (Drug) $80.98
- FreeStyle Libre (Device) $67.91
- TRINTELLIX (Drug) $67.50
- Korlym (Drug) $60.63
- Rybelsus (Drug) $56.68
- ENTRESTO (Drug) $50.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Endwell
Duncan Sze-Tu, Md, MD
Family Medicine — Payments: $15,417
Family Medicine $15,417
Eric Lorraine, Do, DO
Family Medicine — Payments: $12,555
Family Medicine $12,555
John Perry, Md, MD
Family Medicine — Payments: $6,123
Family Medicine $6,123
Kimberly Desantis, Md, MD
Family Medicine — Payments: $5,032
Family Medicine $5,032
Dr. Demetrios Gasparis, M.d, M.D
Family Medicine — Payments: $3,992
Family Medicine $3,992
Jonathan Harris, Md, MD
Family Medicine — Payments: $3,776
Family Medicine $3,776